Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Potentiators for cystic fibrosis - targeting the underlying molecular defect.

Paediatric respiratory reviews - 1 Jun 2015

Patel Sanjay, Sinha Ian P, Dwan Kerry, Echevarria Carlos, Schechter Michael, Southern Kevin W

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aminophenols
Share to Child
Share to Child, Preschool
Share to Chloride Channel Agonists

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cystic Fibrosis

Share to Cystic Fibrosis Transmembrane Conductance Regulator

Share to Quinolones

Share to Respiratory Function Tests

Source

Identifiers

PMID: 26002404
DOI: 10.1016/j.prrv.2015.04.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Potentiators for cystic fibrosis - targeting the underlying molecular defect.PMID 26002404Read ↗

Breakthrough therapies: Cystic fibrosis (CF) potentiators and correctors.Semantic proximity Read ↗

CFTR potentiators: not an open and shut case.Semantic proximity Read ↗

Strategies in early clinical development for the treatment of basic defects of cystic fibrosis.Semantic proximity Read ↗

New pharmacological approaches for cystic fibrosis: promises, progress, pitfalls.Semantic proximity Read ↗

Discovery of CFTR modulators for the treatment of cystic fibrosis.Semantic proximity Read ↗

Pharmacologic approaches to correcting the basic defect in cystic fibrosis.Semantic proximity Read ↗

Molecular basis of cystic fibrosis: from bench to bedsideSemantic proximity Read ↗

Treating the Underlying Cystic Fibrosis Transmembrane Conductance Regulator Defect in Patients with Cystic Fibrosis.Semantic proximity Read ↗

New horizons for cystic fibrosis treatment.Semantic proximity Read ↗

Emerging Therapeutic Approaches for Cystic Fibrosis. From Gene Editing to Personalized MedicineSemantic proximity Read ↗

CFTR Modulators: Shedding Light on Precision Medicine for Cystic FibrosisSemantic proximity Read ↗

Managing the underlying cause of cystic fibrosis: a future role for potentiators and correctors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.